Skip to main content

Table 4 Laboratory Markers in hospitalised COVID-19 patients with the severe and non-severe groups

From: Clinical and laboratory characteristics of patients hospitalised with COVID-19: clinical outcomes in Abu Dhabi, United Arab Emirates

Variables Overall (mean ± SD) Severe (mean ± SD) Non-severe (mean ± SD) P-value
While blood cell count (× 109/L) 6.76 ± 3.69 7.02 ± 3.98 6.74 ± 3.66 0.0635
Lymphocyte count (× 109/L) 1.86 ± 2.72 1.79 ± 0.80 1.89 ± 2.84 0.0056
Neutrophil count (× 109/L) 4.22 ± 2.36 4.73 ± 03.71 4.17 ± 2.17  < 0.0001
Creatinine (µmol/L) 88.32 ± 85.61 104.78 ± 124.10 86.72 ± 80.73  < 0.0001
HbA1c (%) 7.81 ± 2.50 8.42 ± 2.38 7.77 ± 2.50 0.0591
LDH (IU/L) 264.46 ± 128.50 310.10 ± 182.50 259.76 ± 120.62  < 0.0001
Ferritin (mcg/L) 555.95 ± 821.86 768.05 ± 1003.73 534.46 ± 798.09  < 0.0001
CRP (mg/L) 29.51 ± 53.16 56.55 ± 86.87 26.83 ± 47.75  < 0.0000
IL-6 (pg/mL) 158.84 ± 734.08 472.65 ± 1508.39 78.46 ± 255.48  < 0.0000